Group 6 Copy 82
1
Please wait...

About This Project

The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

Working towards a low-cost ostomy bag that doesn't leak

Ostomy bags are a daily medical necessity for 15 million people globally. However, these bags often delaminate...

Tote-Size portable incubator for rapid field work

Waiting for lab results is slowing science down! We are designing a fully open source portable incubator...

Backer Badge Funded